Organ-on-a-chip Market Research Report Information By Organ Type (Lung-on-Chip, Heart-on-Chip, Liver-on-Chip, Intestine-on-Chip, Kidney-on-Chip, Human-on-Chip), By Application (Drug Discovery, Toxicology Research, Others) and By End-User (Pharmaceutical Companies, Research Organizations, Others) – Forecast to 2030
ID: MRFR/HC/7026-HCR | 120 Pages | Author: Rahul Gotadki | June 2023
Table of Contents
1. REPORT PROLOGUE
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Primary Research
3.3. Secondary Research
3.4. Market Size Estimation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Porter’s Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of New Entrants
5.1.4. Threat of Substitutes
5.1.5. Intensity of Rivalry
5.2. Value Chain Analysis
6. GLOBAL ORGAN-ON-A-CHIP MARKET, BY ORGAN TYPE
6.1. Overview
6.2. Lung-on-Chip
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.3. Heart-on-Chip
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.4. Liver-on-Chip
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.5. Intestine-on-Chip
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.6. Kidney-on-Chip
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.7. Skin-on-Chip
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.8. Blood-Brain Barrier-on-Chip
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.9. Human-on-Chip
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.10. Others
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7. GLOBAL ORGAN-ON-A-CHIP MARKET, BY APPLICATION
7.1. Overview
7.2. Drug Discovery
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.3. Toxicology Research
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.4. Others
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8. GLOBAL ORGAN-ON-A-CHIP MARKET, BY ENDUSER
8.1. Overview
8.2. Pharmaceutical Companies
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.3. Research Organizations
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.4. Others
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
9. GLOBAL ORGAN-ON-A-CHIP MARKET, BY REGION
9.1. Overview
9.2. Americas
9.2.1. North America
9.2.1.1. US
9.2.1.2. Canada
9.2.2. Latin America
9.3. Europe
9.3.1. Western Europe
9.3.1.1. Germany
9.3.1.2. France
9.3.1.3. Italy
9.3.1.4. Spain
9.3.1.5. UK
9.3.1.6. Rest of Western Europe
9.3.2. Eastern Europe
9.4. Asia-Pacific
9.4.1. Japan
9.4.2. China
9.4.3. India
9.4.4. Australia
9.4.5. South Korea
9.4.6. Rest of Asia-Pacific
9.5. Middle East & Africa
9.5.1. Middle East
9.5.2. Africa
10. COMPANY LANDSCAPE
10.1. Overview
10.2. Competitive Analysis
10.3. Market Share Analysis
10.4. Major Growth Strategy in the Global Organ-on-a-Chip Market
10.5. Competitive Benchmarking
10.6. Leading Players in terms of Number of Developments in the Global Organ-on-a-Chip Market
10.7. Key Developments and Growth Strategies
10.7.1. Product Launch
10.7.2. Merger & Acquisitions
10.7.3. Joint Ventures
10.8. Major Players Financial Matrix & Market Ratio
10.8.1. Sales & Operating Income 2020
10.8.2. Major Players R&D Expenditure 2020
10.9. Major Players Capital Market Ratio
11. COMPANY PROFILES
11.1. CN Bio Innovations Limited
11.1.1. Company Overview
11.1.2. Financial Overview
11.1.3. Product Offered
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. Emulate
11.2.1. Company Overview
11.2.2. Financial Overview
11.2.3. Product Offered
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. TissUse
11.3.1. Company Overview
11.3.2. Financial Overview
11.3.3. Product Offered
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. Mimetas
11.4.1. Company Overview
11.4.2. Financial Overview
11.4.3. Product Offered
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. Hµrel
11.5.1. Company Overview
11.5.2. Financial Overview
11.5.3. Product Offered
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. Nortis
11.6.1. Company Overview
11.6.2. Financial Overview
11.6.3. Product Offered
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. Insphero
11.7.1. Company Overview
11.7.2. Financial Overview
11.7.3. Product Offered
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. Tara Biosystems
11.8.1. Company Overview
11.8.2. Financial Overview
11.8.3. Product Offered
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
11.9. AxoSim Technologies LLC
11.9.1. Company Overview
11.9.2. Financial Overview
11.9.3. Product Offered
11.9.4. Key Developments
11.9.5. SWOT Analysis
11.9.6. Key Strategies
11.10. Organovo
11.10.1. Company Overview
11.10.2. Financial Overview
11.10.3. Product Offered
11.10.4. Key Developments
11.10.5. SWOT Analysis
11.10.6. Key Strategies
11.11. BioIVT
11.11.1. Company Overview
11.11.2. Financial Overview
11.11.3. Product Offered
11.11.4. Key Developments
11.11.5. SWOT Analysis
11.11.6. Key Strategies
11.12. HemoShear
11.12.1. Company Overview
11.12.2. Financial Overview
11.12.3. Product Offered
11.12.4. Key Developments
11.12.5. SWOT Analysis
11.12.6. Key Strategies
12. APPENDIX
12.1. References
12.2. Related Reports 
LIST OF TABLES
TABLE 1 GLOBAL ORGAN-ON-A-CHIP MARKET SYNOPSIS, 2020-2027
TABLE 2 GLOBAL ORGAN-ON-A-CHIP MARKET ESTIMATES & FORECAST, 2020-2027 (USD MILLION)
TABLE 3 GLOBAL ORGAN-ON-A-CHIP MARKET, BY ORGAN TYPE, 2020-2027 (USD MILLION)
TABLE 4 GLOBAL ORGAN-ON-A-CHIP MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 5 GLOBAL ORGAN-ON-A-CHIP MARKET, BY ENDUSER, 2020-2027 (USD MILLION)
TABLE 6 GLOBAL ORGAN-ON-A-CHIP MARKET, BY REGION, 2020-2027 (USD MILLION)
TABLE 7 NORTH AMERICA: ORGAN-ON-A-CHIP MARKET, BY ORGAN TYPE, 2020-2027 (USD MILLION)
TABLE 8 NORTH AMERICA: ORGAN-ON-A-CHIP MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 9 NORTH AMERICA: ORGAN-ON-A-CHIP MARKET, BY ENDUSER, 2020-2027 (USD MILLION)
TABLE 10 US: ORGAN-ON-A-CHIP MARKET, BY ORGAN TYPE, 2020-2027 (USD MILLION)
TABLE 11 US: ORGAN-ON-A-CHIP MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 12 US: ORGAN-ON-A-CHIP MARKET, BY ENDUSER, 2020-2027 (USD MILLION)
TABLE 13 CANADA: ORGAN-ON-A-CHIP MARKET, BY ORGAN TYPE, 2020-2027 (USD MILLION)
TABLE 14 CANADA: ORGAN-ON-A-CHIP MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 15 CANADA: ORGAN-ON-A-CHIP MARKET, BY ENDUSER, 2020-2027 (USD MILLION)
TABLE 16 LATIN AMERICA: ORGAN-ON-A-CHIP MARKET, BY ORGAN TYPE, 2020-2027 (USD MILLION)
TABLE 17 LATIN AMERICA: ORGAN-ON-A-CHIP MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 18 LATIN AMERICA: ORGAN-ON-A-CHIP MARKET, BY ENDUSER, 2020-2027 (USD MILLION)
TABLE 19 EUROPE: ORGAN-ON-A-CHIP MARKET, BY ORGAN TYPE, 2020-2027 (USD MILLION)
TABLE 20 EUROPE: ORGAN-ON-A-CHIP MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 21 EUROPE: ORGAN-ON-A-CHIP MARKET, BY ENDUSER, 2020-2027 (USD MILLION)
TABLE 22 WESTERN EUROPE: ORGAN-ON-A-CHIP MARKET, BY ORGAN TYPE, 2020-2027 (USD MILLION)
TABLE 23 WESTERN EUROPE: ORGAN-ON-A-CHIP MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 24 WESTERN EUROPE: ORGAN-ON-A-CHIP MARKET, BY ENDUSER, 2020-2027 (USD MILLION)
TABLE 25 EASTERN EUROPE: ORGAN-ON-A-CHIP MARKET, BY ORGAN TYPE, 2020-2027 (USD MILLION)
TABLE 26 EASTERN EUROPE: ORGAN-ON-A-CHIP MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 27 EASTERN EUROPE: ORGAN-ON-A-CHIP MARKET, BY ENDUSER, 2020-2027 (USD MILLION)
TABLE 28 ASIA-PACIFIC: ORGAN-ON-A-CHIP MARKET, BY ORGAN TYPE, 2020-2027 (USD MILLION)
TABLE 29 ASIA-PACIFIC: ORGAN-ON-A-CHIP MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 30 ASIA-PACIFIC: ORGAN-ON-A-CHIP MARKET, BY ENDUSER, 2020-2027 (USD MILLION)
TABLE 31 MIDDLE EAST & AFRICA: ORGAN-ON-A-CHIP MARKET, BY ORGAN TYPE, 2020-2027 (USD MILLION)
TABLE 32 MIDDLE EAST & AFRICA: ORGAN-ON-A-CHIP MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 33 MIDDLE EAST & AFRICA: ORGAN-ON-A-CHIP MARKET, BY ENDUSER, 2020-2027 (USD MILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL ORGAN-ON-A-CHIP MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL ORGAN-ON-A-CHIP MARKET
FIGURE 4 GLOBAL ORGAN-ON-A-CHIP MARKET SHARE, BY ORGAN TYPE, 2020 (%)
FIGURE 5 GLOBAL ORGAN-ON-A-CHIP MARKET SHARE, BY APPLICATION, 2020 (%)
FIGURE 6 GLOBAL ORGAN-ON-A-CHIP MARKET SHARE BY ENDUSER,2020 (%)
FIGURE 6 GLOBAL ORGAN-ON-A-CHIP MARKET SHARE, BY REGION, 2020 (%)
FIGURE 7 AMERICAS: ORGAN-ON-A-CHIP MARKET SHARE BY REGION, 2020 (%)
FIGURE 7 NORTH AMERICA: ORGAN-ON-A-CHIP MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 8 EUROPE: ORGAN-ON-A-CHIP MARKET SHARE, BY REGION, 2020 (%)
FIGURE 9 WESTERN EUROPE: ORGAN-ON-A-CHIP MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 10 ASIA-PACIFIC: ORGAN-ON-A-CHIP MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 11 MIDDLE EAST & AFRICA: ORGAN-ON-A-CHIP MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 12 GLOBAL ORGAN-ON-A-CHIP MARKET: COMPANY SHARE ANALYSIS, 2020 (%)
FIGURE 13 CN BIO INNOVATIONS LIMITED.: KEY FINANCIALS
FIGURE 14 CN BIO INNOVATIONS LIMITED: SEGMENTAL REVENUE
FIGURE 15 CN BIO INNOVATIONS LIMITED: REGIONAL REVENUE
FIGURE 16 EMULATE: KEY FINANCIALS
FIGURE 17 EMULATE: SEGMENTAL REVENUE
FIGURE 18 EMULATE: REGIONAL REVENUE
FIGURE 19 TISSUSE: KEY FINANCIALS
FIGURE 20 TISSUSE: SEGMENTAL REVENUE
FIGURE 21 TISSUSE: REGIONAL REVENUE
FIGURE 22 MIMETAS: KEY FINANCIALS
FIGURE 23 MIMETAS: SEGMENTAL REVENUE
FIGURE 24 MIMETAS: REGIONAL REVENUE
FIGURE 25 HµREL: KEY FINANCIALS
FIGURE 26 HµREL: SEGMENTAL REVENUE
FIGURE 27 HµREL: REGIONAL REVENUE
FIGURE 28 NORTIS: KEY FINANCIALS
FIGURE 29 NORTIS: SEGMENTAL REVENUE
FIGURE 30 NORTIS: REGIONAL REVENUE
FIGURE 31 TARA BIOSYSTEMS: KEY FINANCIALS
FIGURE 32 TARA BIOSYSTEMS: SEGMENTAL REVENUE
FIGURE 33 TARA BIOSYSTEMS: REGIONAL REVENUE
FIGURE 34 INSPHERO: KEY FINANCIALS
FIGURE 35 INSPHERO: SEGMENTAL REVENUE
FIGURE 36 INSPHERO: REGIONAL REVENUE
FIGURE 37 AXOSIM TECHNOLOGIES LLC: KEY FINANCIALS
FIGURE 38 AXOSIM TECHNOLOGIES LLC: SEGMENTAL REVENUE
FIGURE 39 AXOSIM TECHNOLOGIES LLC: REGIONAL REVENUE
FIGURE 40 ASCENDANCE: KEY FINANCIALS
FIGURE 41 ASCENDANCE: SEGMENTAL REVENUE
FIGURE 42 ASCENDANCE: REGIONAL REVENUE
FIGURE 43 HEMOSHEAR: KEY FINANCIALS
FIGURE 44 HEMOSHEAR: SEGMENTAL REVENUE
FIGURE 45 HEMOSHEAR: REGIONAL REVENUE
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Research Methodology on Organ on Chip Market
Introduction
Organ-on-Chip (OoC) technology is an innovative technology that is revolutionizing the biomedical research field. It involves the creation of miniature lab-on-chip systems containing living cells, micro-channels, sensors, actuators and other related components. It has enabled researchers to bypass the traditional bottlenecks associated with animal studies, enabling them to develop more effective drugs that have a higher rate of success and faster results than conventional drug development studies. This technology has also enabled researchers to simulate more complex human physiology more accurately, which in turn has allowed the development of personalized medicines and treatments.
The purpose of this research project is to understand the current market size of the Organ-on-Chip technology, identify the key products in the market, determine the future growth of the technology, and assess the market potential of the technology.
Research Objectives
Research Questions
Research Approach
This research will employ descriptive, as well as exploratory research approaches in order to gain an in-depth understanding of the Organ-on-Chip technology market. Descriptive research is used to analyze the size and scope of the current Organ-on-Chip technology market and identify the key players in the industry. Exploratory research is employed to gain a better understanding of the growth potential of the technology, as well as identify the threats and opportunities present in the market.
Research Design
The research employs both qualitative and quantitative research designs. The qualitative design involves semi-structured interviews with key industry experts and stakeholders, as well as analyzing secondary sources including reports, industry white papers, and other available data. The quantitative design involves surveys and polls, as well as analysis of the data, gathered through qualitative research.
Sampling & Data Collection
The sample size for the research will be 1000 respondents, strategically chosen to provide a comprehensive overview of the Organ-on-Chip technology market. The sample includes representatives from key sectors of the industry, such as manufacturers of technology, agricultural and pharmaceutical companies, research institutions, government agencies, as well as other stakeholders. The data is collected using both primary and secondary methods. Primary methods include surveys and face-to-face interviews, while secondary methods involve analysis of available published documents, industry reports, and other available data.
Data Analysis
The collected data is analyzed using both quantitative and qualitative methods. Quantitative data analysis tools such as SPSS and Excel are utilized to analyze the collected data statistically and to generate results from the surveys and polls. Qualitative data analysis methods, such as content analysis and thematic analysis, are used to analyze the interviews conducted with experts and stakeholders.
Conclusion
The organ-on-chip technology market has enormous potential and could revolutionize the research and drug development sector. This research provides an in-depth understanding of the current market size and scope, the key players in the industry, the potential growth of the technology, as well as the threats and opportunities present in the market. The findings of this research prove to be beneficial for key stakeholders in the industry.
